CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

NRSNNeuroSense Therapeutics Ltd.

NASDAQ · Pharmaceutical Preparations
Last close $4.43 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-06-17 · Ben-Noon Alon (Chief Executive Officer) · BUY
  • 2026-06-17 · Eisenberg Or (Chief Financial Officer) · BUY
  • 2026-04-01 · Eisenberg Or (Chief Financial Officer) · OTHER
  • 2026-03-30 · Binder Hagit (General Manager) · OTHER
  • 2026-03-30 · Russek-Blum Niva (Chief Technology Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders12
Shares held397,612
Value$278.76K
Percent of shares outstanding1.22%
As of quarter end2026-06-30
RECENT NEWS
  • NRSN halted · Volatility pause (LULD)
  • NeuroSense to participate in ROTH Healthcare Opportunities Conference
  • NeuroSense Therapeutics reports GAAP EPS of -$2.10
  • NeuroSense provides business update for first half of 2026
  • NRSN halted · News pending
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
NeuroSense Therapeutics Ltd. (NRSN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit